Joseph Truluck

Joseph Truluck is a declared insider of Adial Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). Between 31 July 2018 and 23 May 2023, the trades on record add up to 3 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The newest entry dates from 25 May 2023: a share grant, in Adial Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.